• LAST PRICE
    0.2580
  • TODAY'S CHANGE (%)
    Trending Down-0.0018 (-0.6925%)
  • Bid / Lots
    0.2566/ 25
  • Ask / Lots
    0.2600/ 8
  • Open / Previous Close
    0.2661 / 0.2598
  • Day Range
    Low 0.2558
    High 0.2900
  • 52 Week Range
    Low 0.2504
    High 11.2900
  • Volume
    209,241
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.25979
TimeVolumeREVB
09:32 ET3550.2661
09:34 ET521860.286096
09:36 ET297000.2799
09:39 ET8180.2674
09:43 ET2000.2798
09:48 ET10190.2561
09:52 ET1000.2569
09:54 ET25350.2558
09:56 ET3000.257
09:57 ET14000.2698
10:03 ET1000.2591
10:06 ET1000.2692
10:10 ET44000.2591
10:14 ET1000.26
10:15 ET1000.2673
10:17 ET1000.26
10:19 ET5000.27
10:21 ET1000.2591
10:28 ET2810.27
10:32 ET20370.2591
10:33 ET2000.2673
10:35 ET1000.261
10:39 ET5260.268
10:44 ET1000.261
10:50 ET1000.261
10:53 ET1000.261
10:57 ET1000.261
11:00 ET14000.268
11:13 ET2000.2679
11:18 ET10000.278
11:24 ET2000.27
11:27 ET13000.27
11:29 ET1000.27
11:31 ET188390.27332
11:42 ET26280.269
11:44 ET1000.269
11:45 ET5000.269
11:49 ET1000.2591
11:54 ET1000.258
11:56 ET29000.258001
11:58 ET14000.2607
12:02 ET1000.26
12:09 ET20000.265
12:16 ET2000.26
12:18 ET1000.26
12:23 ET161000.26
12:27 ET1000.26
12:32 ET2400.268
12:34 ET1000.2616
12:43 ET2000.2616
12:52 ET5000.265899
12:54 ET5000.267799
12:57 ET5000.264
01:03 ET1000.2601
01:06 ET1000.2601
01:17 ET2000.2601
01:24 ET1000.2601
01:28 ET1000.2601
01:32 ET126480.258
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesREVB
Revelation Biosciences Inc
6.1M
-0.2x
---
United StatesKRBP
Kiromic Biopharma Inc
5.4M
-0.2x
---
United StatesCAPS
Capstone Therapeutics Corp
5.8M
-5.6x
---
United StatesNPHC
Nutra Pharma Corp
6.1M
0.4x
---
United StatesPBLA
Panbela Therapeutics Inc
7.1M
-0.2x
---
United StatesMHTX
Manhattan Scientifics Inc
6.5M
-1.9x
---
As of 2022-09-27

Company Information

Revelation Biosciences, Inc., formerly Petra Acquisition, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the development or commercialization of innate immune system therapeutics and diagnostics. Its clinical and nonclinical stage therapeutic and diagnostic platforms is applied to a range of viral infections, including SARS-CoV-2, variants of SARS-CoV-2, Influenza A, Influenza B, parainfluenza, respiratory syncytial virus, rhinosinusitis, and others. Its lead therapeutic product candidate includes REVTx-99, REVTx-200 and REVDx-501. REVTx-99 is developed as an anti-viral nasal drop for the prevention or treatment of respiratory viral infections, including nasal congestion due to allergies or chronic rhinosinusitis. REVTx-200 is developed as an intranasal therapy that is administered with intramuscular (IM) vaccine. REVDx-501 (REVID Rapid Test Kit) is a lead diagnostic device program, which is developed to detect various respiratory viral infection.

Contact Information

Headquarters
4660 Lajolla Village Drive, Suite 100SAN DIEGO, CA, United States 92122
Phone
650-800-3717
Fax
302-645-1280

Executives

Independent Chairman of the Board
George Tidmarsh
Chief Executive Officer, Co-Founder, Director
James Rolke
Chief Financial Officer
Chester Zygmont
Independent Director
Jennifer Carver
Independent Director
Curt Labelle

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$6.1M
Revenue (TTM)
$0.00
Shares Outstanding
23.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.67
Book Value
$6.10
P/E Ratio
-0.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.